Colony stimulating factors: G-CSFs--filgrastim (Neupogen) and lenograstim (Granocyte)

The introduction of leucocyte growth factors produced by DNA biosynthetic technology has had a major impact on survival in patients with compromised immunity. Such agents have maximized the benefits of treatment with drugs which are otherwise potentially toxic to the bone marrow.